Echoplanar chemical shift imaging

Magnetic Resonance in Medicine

Volumn 41, Issue 5, 1999, Pages 877-882

  Guimaraes, A R ^a   Baker, J R ^a   Jenkins, B G ^a   Lee, P L ^a   Weisskoff, R M ^a   Rosen, B R ^a   Gonzalez R G ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemical shift imaging; Echoplanar imaging; N acetyl aspartate; Neurodegeneration

Indexed keywords

IMAGE ENHANCEMENT; IMAGE RESOLUTION; METABOLITES; SIGNAL TO NOISE RATIO;

CHEMICAL SHIFT IMAGING; ECHO PLANAR IMAGING; HIGH SPATIAL RESOLUTION; N-ACETYL ASPARTATE; NEURODEGENERATION; SPATIAL RESOLUTION;

CHEMICAL SHIFT;

N ACETYLASPARTIC ACID;

ARTICLE; BRAIN METABOLISM; HUMAN; IMAGE PROCESSING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; RADIOFREQUENCY; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING;

EID: 0032924415     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2594(199905)41:5<877::AID-MRM4>3.0.CO;2-3     Document Type: Article

References (31)

1. Brown T, Kincaid B, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 1982;79:3523-3526.
2. Pykett I, Rosen B. Nuclear magnetic resonance: in-vivo proton chemical shift imaging. Radiology 1983;149:197-201.
3. Mulkern R, Chao H, Bowers J, Holtzman D. Multiecho approaches to spectroscopic imaging of the brain. Ann NY Acad Sci 1997;820:97-122.
4. Duyn J, Moonen C. Fast proton spectroscopic imaging of human brain using multiple spin-echoes. Magn Reson Med 1993;30:409-414.
5. Posse S, DeCarli C, Le Bihan D. Three-dimensional echo-planar MR spectroscopic imaging at short echo times in the human brain. Radiology 1994;192:733-738.
6. Posse S, Tedeschi G, Risinger R, Ogg R, LeBihan D. High speed 1H spectroscopic imaging in human brain by echo planar spatial-spectral encoding. Magn Reson Med 1995;33:34-40.
7. Mansfield P. Spatial mapping of the chemical shift in NMR. Magn Reson Med 1984;1:370-386.
8. Guimaraes A, Hoppel B, Weisskoff R, Rosen B, Gonzalez R. Echo planar chemical shift imaging. In: Proceedings of the Eleventh Annual Meeting of the Society of Magnetic Resonance in Medicine, Berlin, 1992.
9. Sepponen R, Sipponen J, Tanttu J. A method for chemical shift imaging: demonstration of bone marrow involvement with proton chemical shift imaging. J Comput Assist Tomogr 1984;8:585-587.
10. Dixon W. Simple proton spectroscopic imaging. Radiology 1984;153: 189-194.
11. Ryner L, Sorenson J, Thomas M. 3D localized 2D NMR spectroscopy on an MRI scanner. J Magn Reson B 1995;107:126-137.
12. Hore P. Solvent suppression in fourier transform nuclear magnetic resonance. J Magn Reson 1983;55:283-300.
13. Reese T, Davis T, Weisskoff R. Automated shimming at 1.5T using echo-planar image frequency maps. J Magn Reson Imaging 1995;5:739-745.
14. nd ed. Englewood Cliffs, NJ: Prentice-Hall; 1989. p 880.
15. Tallan H, Moore S, Stein W. N-acetyl-L-aspartic acid in brain. J Biol Chem 1956;219:257-264.
16. Nadler J, Cooper J. N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues. J Neurochem 1972;14: 551-554.
17. Koller K, Zaczek R, Coyle J. N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 1984;43:1138-1142.
18. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45:37-45.
19. Menon D, Ainsworth J, Cox I, Coker R, Sargentoni J, Coutts G, Baudouin C, Kocsis A, Harris J. Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 1992;16:538-542.
20. Miller B, Moats R, Shonk T, Ernst T, Woolley S, Ross B. In vivo abnormalities of cerebral myo-inositol and n-acetyl residues in Alzheimer disease. Radiology 1992.
21. Miller B, Moats R, Shonk T, Ernst T, Woolley S, Ross B. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993;187:433-437.
22. Jarvik J, Lenkinski R, Grossman R, Gomori J, Schnall M, Frank I. Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 1993;186:739-744.
23. Kreis R, Ernst T, Ross B. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-437.
24. Chong W, Paley M, Wilkinson I, Hall-Craggs M, Sweeney B, Harrison M, Miller R, Kendall B. Localised cerebral proton MR spectroscopy in HIV infection and AIDS. AJNR 1994;15:21-25.
25. Guimaraes AR, Schwartz P, Prakash MR, Carr CA, Berger UV, Jenkins BG, Coyle JT, Gonzalez RG. Quantitative in vivo 1H NMR spectroscopic imaging of excitotoxicity in rat brain. Neuroscience 1995;69:1095-1101.
26. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology 1996;46:783-788.
27. 1H magnetic resonance spectroscopy reveals neuronal injury in a simian immunodeficiency virus macaque model. J AIDS 1997;15:21-27.
28. Cheng LL, Ma MJ, Becerra L, Ptak T, Tracey I, Lackner A, Gonzalez RG. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA 1997;94:6408-6413.
29. Mansfield P, Morris P. Comparison of imaging methods. In: NMR imaging in biomedicine. New York, Academic Press; 1982.
30. Deichmann R, Holger A, Noth U, Kuchenbrod E, Schwarzbauer C, Haase A. Calculation of signal intensities in hybrid sequences for fast NMR imaging. Magn Reson Med 1995;34:481-489.
31. Hetherington H, Pan J, Mason G, Adams D, Vaughn D, Pohost G. 2D 1H spectroscopic imaging of the human brain at 4.1T. Magn Reson Med 1996;36:21-29.